Advances in the treatment of cervical esophageal cancer
10.3781/j.issn.1000-7431.2025.2405-0308
- VernacularTitle:颈段食管癌治疗的研究进展
- Author:
Min ZHU
1
;
Tiane ZHANG
1
;
Ziguo LIU
1
;
Hai ZENG
1
Author Information
1. 长江大学附属第一医院肿瘤科,湖北 荆州 434000
- Publication Type:Journal Article
- Keywords:
Cervical esophageal cancer;
Chemotherapy;
Radiotherapy;
Concurrent chemoradiotherapy;
Immunotherapy
- From:
Tumor
2025;45(1):55-65
- CountryChina
- Language:Chinese
-
Abstract:
Cervical esophageal cancer(CEC)is a relatively rare pathological subtype of esophageal cancer,accounting for 2%～10%of all esophageal cancer cases,95%of which are esophageal squamous cell carcinoma.Due to nonspecific clinical symptoms,most CEC patients are diagnosed at advanced or locally advanced stages,resulting in a 5-year overall survival(OS)rate of approximately 30%.Although therapeutic outcomes for CEC patients remain suboptimal,current studies have demonstrated the clinical value of multiple treatment modalities,including endoscopic therapy,photodynamic therapy,selective or salvage surgery,radiotherapy,chemotherapy,concurrent chemoradiotherapy(CCRT),immunotherapy,and targeted therapy.This article systematically reviews recent advances in CEC management,focusing on the aforementioned approaches,and delves into the optimal treatment strategies,aiming to provide a scientific and reliable foundation for clinical practise.
